No definition available.
Disorders of male genital organs in diseases classified elsewhere
EFO MESH Endpoint Browser PheWeb
N14_MALEGENINOTH
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleonly males |
244368 |
2. Check conditionsNone |
244368 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
273 |
4. Check minimum number of eventsNone |
273 |
5. Include endpointsNone |
273 |
6. Filter based on genotype QC (FinnGen only) |
245 |
Control definitions (FinnGen only)
- Control exclude
- N14_MALEGEN
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Disorders of male genital organs in diseases classified elsewhere
based on the number of shared cases.
Similar with more cases:
- Diseases of male genital organs
- Genitourinary diseases
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2125 | - | 2125 |
| Only index persons | 2038 | - | 2038 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | - | 0.06 |
| Only index persons | 0.08 | - | 0.08 |
| Median age at first event (years) | |||
| Whole population | - | - | 34.45 |
| Only index persons | - | - | 34.35 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 245 | - | 245 |
| Unadjusted period prevalence (%) | 0.11 | - | 0.11 |
| Median age at first event (years) | 47.71 | - | 47.71 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 256
- Matched controls
- 2560
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N51.8*A60.0
ICD-10 Finland
Herpes simplex infection of the genitals in men
501.7
122.7
113
*
N51.2*B37.4
ICD-10 Finland
Candidal balanitis
276.9
64.4
63
*
N48.1
ICD-10 Finland
Balanoposthitis
19.5
57.9
48
30
J05AB11
ATC
valaciclovir; oral
7.2
44.7
84
163
N51.2
ICD-10 Finland
Balanitis in diseases classified elsewhere
215.2
36.8
37
*
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
7.0
31.7
55
96
J05AB01
ATC
aciclovir; systemic
5.1
29.8
81
214
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
8.5
28.0
39
53
J02AC01
ATC
fluconazole; systemic
4.6
26.6
84
248
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
4.1
24.9
95
321
KGH10
NOMESCO Finland
Operation for phimosis
216.0
19.8
20
*
N51.8
ICD-10 Finland
Other disorders of male genital organs in diseases classified elsewhere
216.0
19.8
20
*
A60.0
ICD-10 Finland
Herpesviral infection of genitalia and urogenital tract
23.1
19.1
27
13
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
4.7
18.5
48
119
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
35.9
18.3
23
7
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
21.1
17.2
25
13
N40
ICD-10 Finland
Hyperplasia of prostate
3.5
15.9
69
246
UKC02
NOMESCO Finland
Cystoscopy
4.2
15.4
46
127
XKD00
NOMESCO Finland
Uroflowmetry
4.0
14.2
46
134
G04CB01
ATC
finasteride; oral
4.0
13.3
42
120
J01MA02
ATC
ciprofloxacin; systemic
2.7
13.0
108
547
N03AF01
ATC
carbamazepine; oral, rectal
5.9
12.4
23
42
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
3.2
11.4
51
183
A63.0
ICD-10 Finland
Anogenital (venereal) warts
5.6
11.3
22
42
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.9
11.3
65
270
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.4
10.7
128
753
KED22
NOMESCO Finland
Transurethral resection of prostate
34.1
10.4
13
*
N02BF01
ATC
gabapentin; oral
3.8
10.3
33
95
G04CA01
ATC
alfuzosin; oral
2.9
10.1
57
233
N41.1
ICD-10 Finland
Chronic prostatitis
8.7
10.1
21
26
N02AX02
ATC
tramadol; systemic, rectal
2.3
9.8
122
722
N51.1
ICD-10 Finland
Disorders of testis and epididymis in diseases classified elsewhere
57.2
9.7
11
*
A56.0
ICD-10 Finland
Chlamydial infection of lower genitourinary tract
9.7
9.7
19
21
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
4.0
9.4
28
76
G04CA02
ATC
tamsulosin; oral
2.4
9.3
85
438
H04.10
ICD-10 Finland
Dry eye syndrome
3.6
9.2
32
97
N03AX12
ATC
[U] gabapentin; oral
2.9
9.1
48
188
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
9.0
135
855
J01MA01
ATC
ofloxacin; systemic
4.2
8.9
25
65
K08.80
ICD-10 Finland
Toothache NOS
3.8
8.8
28
80
D07AC01
ATC
betamethasone; topical
2.3
8.6
99
560
G04CB02
ATC
dutasteride; oral
3.7
8.3
28
83
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
8.0
8.3
18
24
N03AE01
ATC
clonazepam; systemic
4.3
8.3
22
55
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.7
8.2
51
218
Y04
ICPC
Penis symptom/complaint other
12.3
8.2
14
12
K30
ICD-10 Finland
Functional dyspepsia
3.3
7.9
31
102
M03BX02
ATC
tizanidine; oral
2.1
7.9
158
1100
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
7.9
88
490
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.4
7.8
30
97
N06AX21
ATC
duloxetine; oral
3.2
7.8
32
108
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.9
7.8
41
160
N48.8
ICD-10 Finland
Other specified disorders of penis
46.4
7.8
9
*
N03AX16
ATC
[U] pregabalin
2.4
7.6
60
287
WZC00
NOMESCO Finland
Treatment plan or consultation
2.1
7.6
97
568
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
7.5
65
325
J01DB01
ATC
cefalexin; oral
2.5
7.3
213
1699
J01DA01
ATC
[U] cefalexin
2.0
7.2
150
1047
M79.6
ICD-10 Finland
Pain in limb
2.1
7.1
108
672
J02AC02
ATC
itraconazole; systemic
2.7
7.0
41
169
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
4.2
7.0
19
48
M01AB05
ATC
diclofenac; systemic, rectal
2.1
7.0
176
1310
D07AB02
ATC
hydrocortisone butyrate; topical
2.2
6.9
73
394
R31
ICD-10 Finland
Unspecified haematuria
3.1
6.7
29
101
R07.4
ICD-10 Finland
Chest pain, unspecified
2.1
6.7
75
415
L03
ICPC
Low back symptom/complaint
2.1
6.7
75
415
J01MA12
ATC
levofloxacin; systemic
2.4
6.6
49
227
G04BD12
ATC
mirabegron; oral
3.3
6.6
26
86
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.5
6.5
46
208
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.9
6.4
131
895
KED52
NOMESCO Finland
Visual laser resection of prostate
+∞
6.3
6
*
KGB00
NOMESCO Finland
Biopsy of penis
+∞
6.3
6
*
A18.1
ICD-10 Finland
Tuberculosis of genitourinary system
+∞
6.3
6
*
D07AD01
ATC
clobetasol; topical
2.5
6.2
42
186
R12
ICD-10 Finland
Heartburn
3.3
6.2
24
78
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
3.1
6.2
26
89
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.0
6.1
28
101
A02BC05
ATC
esomeprazole; systemic
2.0
6.1
93
573
D06BB04
ATC
podophyllotoxin; topical
3.3
6.1
23
74
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.6
6.0
36
150
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
78
239
4.26
23.24
2.4
2.3
—
—
—
0
0
81
262
4.06
22.31
2.4
2.4
—
—
—
0
0
26
22
13.01
14.95
1.2
1.4
—
—
—
0
0
53
208
2.95
10.11
5.5
4.2
30.03
28.97
%
0.25
34
137
206
1529
2.78
9.92
10.6
9.2
76.21
80.66
u/l
0.63
199
1473
194
1411
2.55
9.53
5.7
4.1
10.25
11.12
mm/h
0.29
182
1322
144
931
2.25
9.18
10.3
9.7
1.20
1.20
mmol/l
0.34
130
828
133
858
2.14
8.23
7.5
5.9
36.87
36.26
g/l
0.58
127
814
140
932
2.11
7.86
3.3
2.9
0.00
0.00
estimate
-0.00
13
184
140
937
2.09
7.69
3.3
2.9
0.00
9.77
estimate
0.50
15
179
129
842
2.07
7.54
9.5
9.1
1.20
1.20
mmol/l
0.33
120
791
140
945
2.06
7.43
3.4
2.9
0.00
1.82
estimate
0.50
14
165
240
2030
3.92
7.41
21.7
15.2
20.79
26.30
mg/l
2.02
209
1657
25
84
3.19
6.15
2.0
2.9
—
—
—
0
0
14
23
6.37
5.78
1.4
2.3
7.14
22.00
mg/l
—
7
8
25
88
3.04
5.70
4.8
3.2
—
—
—
0
0
69
394
2.03
5.52
3.3
4.1
1810.63
761.52
ng/l
0.34
51
314
23
79
3.10
5.46
2.0
2.7
—
—
—
0
0
121
836
1.85
5.45
2.9
2.8
—
—
estimate
—
0
0
63
351
2.05
5.38
1.5
1.4
—
—
—
0
0
211
1755
2.15
5.24
5.2
3.8
1.79
1.92
mu/l
1.11
189
1630
151
1128
1.83
5.18
12.0
11.7
4.00
4.18
e9/l
0.52
136
991
156
1180
1.82
5.11
7.6
6.8
7.02
6.87
mmol/l
0.34
149
1143
108
734
1.82
5.03
2.6
2.4
71.84
71.56
nmol/l
0.04
95
677
29
119
2.62
5.01
3.2
3.4
0.88
1.66
mmol/l
0.78
24
87
60
337
2.02
4.98
2.1
1.9
—
—
—
0
0
94
615
1.84
4.94
4.5
3.0
54.78
66.12
u/l
0.85
89
587
114
792
1.79
4.90
2.2
2.0
99.55
91.31
pmol/l
0.87
57
463
84
532
1.86
4.89
2.2
2.5
0.00
0.18
estimate
0.52
11
144
69
412
1.92
4.80
2.0
1.9
0.98
1.59
mg/l
1.01
55
319
16
48
3.49
4.69
1.8
1.5
240.63
249.86
ug/g
—
8
33
114
801
1.76
4.66
5.4
3.6
30.76
47.90
ng/l
1.02
84
568
99
675
1.76
4.44
5.5
4.4
4.31
8.66
mg/mmol
1.52
64
467
171
1365
1.76
4.31
3.7
3.0
14.85
14.80
pmol/l
0.08
156
1261
7
6
11.94
4.30
1.0
1.0
—
—
—
0
0
118
859
1.69
4.11
1.8
1.9
1.50
1.49
mmol/l
0.04
106
735
165
1314
1.72
4.10
6.0
4.1
7.68
1.85
ug/l
0.55
151
1174
103
725
1.70
4.05
3.0
2.9
0.00
0.00
estimate
-0.00
11
159
8
11
7.46
3.89
1.5
1.0
—
—
—
0
0
17
60
2.96
3.87
2.1
1.6
—
—
—
0
0
13
33
4.09
3.85
1.2
1.1
—
—
—
0
0
14
44
3.31
3.83
1.7
3.0
—
1493.33
—
0
6
68
439
1.75
3.59
2.9
2.4
13.82
14.40
nmol/l
0.25
57
410
70
462
1.71
3.40
2.4
2.7
—
—
—
0
0
232
2089
2.18
3.38
24.9
18.5
4.02
4.02
mmol/l
0.15
226
2051
8
14
5.86
3.36
1.0
1.2
—
—
—
0
0
105
772
1.61
3.34
4.5
4.0
29.76
40.72
u/l
2.68
97
734
39
216
1.95
3.33
4.0
4.3
1.46
1.51
mmol/l
0.03
34
190
8
15
5.47
3.21
1.5
1.0
—
—
—
0
0
81
564
1.64
3.19
4.4
3.9
2.34
2.34
mmol/l
0.14
76
520
164
1352
1.59
3.13
3.5
2.9
—
—
—
0
0
64
422
1.69
3.09
3.7
3.0
1.02
1.02
kg/l
0.19
43
264
243
2246
2.61
3.05
16.0
11.4
31.41
33.24
u/l
0.86
237
2204
26
128
2.15
3.04
1.5
1.7
—
—
—
0
0
27
135
2.12
3.04
11.1
21.2
17.15
16.09
%
0.72
27
127
230
2082
2.03
3.02
24.9
18.3
139.72
139.67
mmol/l
0.11
225
2047
80
563
1.61
2.99
3.0
3.0
352.20
376.32
umol/l
1.42
69
510
5
5
10.16
2.99
1.6
1.2
—
—
—
0
0
39
226
1.86
2.91
3.8
4.2
5.76
5.73
kpa
0.05
39
221
7
13
5.50
2.89
2.0
2.4
784.43
779.62
u/ml
—
7
13
43
259
1.79
2.84
1.3
1.3
1.43
13.55
u/ml
1.61
12
109
70
483
1.62
2.82
3.6
3.0
0.00
0.01
estimate
0.50
15
161
5
6
8.47
2.76
2.2
1.5
—
—
—
0
0
79
565
1.58
2.73
4.2
3.6
1498.08
1339.55
ng/l
0.11
69
482
232
2124
1.98
2.67
5.5
4.9
4.61
4.55
mmol/l
0.40
218
2017
33
187
1.88
2.65
5.5
7.6
—
—
—
0
0
44
274
1.73
2.60
1.5
1.2
10.60
38.71
iu/ml
—
9
85
234
2153
2.01
2.58
6.2
5.3
2.73
2.75
mmol/l
0.16
216
2035
26
137
2.00
2.57
3.0
4.5
24.58
24.01
mmol/l
0.46
26
137
5
7
7.26
2.56
1.4
1.1
—
—
—
0
0
29
160
1.92
2.52
1.3
1.4
—
—
—
0
0
231
2120
1.92
2.51
5.5
4.7
1.26
1.28
mmol/l
0.33
212
1999
12
45
2.75
2.49
1.6
1.1
—
—
—
0
0
8
21
3.90
2.48
1.4
1.1
—
—
—
0
0
103
796
1.49
2.46
3.1
2.7
179.77
191.82
ug/l
0.13
94
755
42
264
1.71
2.40
2.0
1.8
—
—
—
0
0
8
22
3.72
2.38
1.1
1.5
—
—
—
0
0
8
22
3.72
2.38
1.4
1.1
—
—
—
0
0
8
22
3.72
2.38
1.1
1.5
—
—
—
0
0
8
22
3.72
2.38
1.1
1.5
—
—
—
0
0
15
65
2.39
2.36
2.3
1.9
—
—
—
0
0
8
23
3.56
2.29
1.1
1.5
—
—
—
0
0
8
23
3.56
2.29
1.1
1.5
—
—
—
0
0
8
23
3.56
2.29
1.1
1.5
—
—
—
0
0
41
260
1.69
2.27
9.9
14.3
1.47
0.65
mmol/l
1.10
35
211
40
254
1.68
2.21
1.7
1.9
—
—
—
0
0
7
19
3.76
2.16
1.1
1.1
—
—
—
0
0
62
443
1.53
2.11
2.2
2.2
2.52
2.94
mg/l
0.76
48
398
41
267
1.64
2.06
1.8
1.6
900.67
1026.85
nmol/l
0.56
28
211
19
97
2.04
2.06
6.2
10.2
1.75
1.69
%
0.13
19
89
26
150
1.82
2.00
2.0
1.6
—
—
—
0
0
123
1013
1.41
1.99
5.2
3.5
20.46
22.38
%
0.58
52
382
217
1987
1.60
1.99
8.1
5.9
41.16
39.13
mmol/mol
2.10
199
1897
34
213
1.69
1.98
10.2
13.1
1.32
1.37
mmol/l
0.18
34
208
15
71
2.18
1.96
2.8
2.4
23.94
24.94
mmol/l
0.74
15
71
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
11
4.61
1.95
1.4
1.2
—
—
—
0
0
5
11
4.61
1.95
2.6
1.1
—
—
—
0
0
6
16
3.81
1.94
1.3
1.0
—
—
—
0
0
19
100
1.97
1.91
1.9
2.3
39.41
39.93
u/l
0.03
19
88
23
130
1.85
1.89
2.9
3.1
0.56
0.62
%
0.53
23
130
29
177
1.72
1.86
1.8
2.3
11.42
12.10
ug/l
0.05
22
164
56
403
1.50
1.84
1.3
1.3
0.80
1.06
u/ml
0.45
13
127
34
218
1.65
1.82
10.1
9.8
9.30
9.84
mmol/l
0.21
34
210
8
29
2.81
1.80
1.6
1.1
—
—
—
0
0
14
67
2.15
1.79
1.2
1.4
—
—
—
0
0
219
2023
1.57
1.77
4.7
4.1
1.54
1.40
mmol/l
1.50
199
1901
15
75
2.06
1.73
2.3
1.6
0.13
0.07
iu/ml
—
5
15
5
13
3.90
1.72
1.0
1.5
—
—
—
0
0
182
1629
1.41
1.68
5.2
3.4
43.33
56.49
u/l
3.36
174
1570
7
25
2.85
1.66
1.3
2.1
13.14
11.08
mmol/l
—
7
25
12
56
2.20
1.64
1.9
1.3
—
—
—
0
0
5
14
3.62
1.62
1.8
1.0
1548.50
1335.79
miu/ml
—
5
14
41
284
1.53
1.61
3.0
2.8
25.97
23.79
%
0.35
35
276
43
303
1.50
1.56
3.4
2.8
0.24
0.43
e6/l
0.63
25
151
46
329
1.49
1.56
3.1
2.8
14.16
13.42
umol/l
0.27
41
312
212
1960
1.47
1.55
6.2
4.7
6.24
6.03
mmol/l
0.97
190
1825
65
498
1.41
1.54
1.7
1.7
17.27
18.15
nmol/l
0.18
51
432
33
223
1.55
1.45
11.6
16.1
131.79
125.03
g/l
0.84
33
215
215
2000
1.47
1.45
17.7
14.4
86.67
86.08
ml/min/173m2
0.15
197
1836
65
503
1.39
1.45
3.5
3.0
0.14
0.54
e6/l
1.68
47
367
16
88
1.87
1.45
3.5
1.9
0.58
1.19
ug/l
0.47
16
76
9
39
2.35
1.44
1.7
1.5
—
—
—
0
0
9
39
2.35
1.44
1.0
1.2
—
—
—
0
0
43
309
1.47
1.43
3.4
2.8
2.28
2.27
g/l
0.03
37
291
9
40
2.29
1.41
1.6
1.7
—
—
—
0
0
44
319
1.46
1.40
3.5
2.7
0.51
0.93
e6/l
0.81
27
167
6
23
2.65
1.37
2.8
2.0
—
—
—
0
0
6
24
2.53
1.31
2.0
2.0
—
—
—
0
0
12
62
1.98
1.30
1.5
1.8
—
—
—
0
0
6
25
2.43
1.25
1.0
1.0
—
—
—
0
0
6
25
2.43
1.25
2.8
2.0
—
—
—
0
0
16
93
1.77
1.24
1.1
1.1
—
—
—
0
0
8
37
2.20
1.22
1.0
1.2
—
—
—
0
0
11
57
1.97
1.19
1.2
1.0
—
4.93
—
0
8
8
39
2.08
1.16
1.3
1.8
—
—
—
0
0
10
51
2.00
1.13
1.6
1.6
—
—
—
0
0
28
194
1.50
1.12
3.6
2.4
29.21
35.28
u/l
0.95
28
162
15
89
1.73
1.10
1.3
2.1
1.51
1.53
g/l
0.05
15
82
7
33
2.15
1.06
1.1
1.2
160.29
185.68
pmol/l
—
7
33
5
22
2.30
1.04
2.0
4.0
482.60
1575.00
mg
—
5
22
7
34
2.09
1.03
1.7
1.5
—
—
—
0
0
10
54
1.89
0.98
1.4
1.2
—
—
—
0
0
18
118
1.57
0.93
1.7
1.7
—
—
—
0
0
16
103
1.59
0.90
1.3
1.4
—
—
—
0
0
6
31
1.96
0.85
1.3
1.4
—
—
—
0
0
20
139
1.48
0.82
4.2
2.8
74.20
64.19
ml/min/173m2
—
10
59
87
758
1.22
0.78
3.3
2.4
0.70
0.73
ug/l
0.15
53
401
9
55
1.66
0.74
1.4
1.5
—
—
—
0
0
5
25
2.02
0.73
2.4
3.2
107.20
106.04
mmol/l
—
5
25
5
25
2.02
0.73
2.4
3.2
1.20
1.20
mmol/l
—
5
25
9
58
1.57
0.70
3.4
6.3
27.70
50.48
mg/l
—
9
52
9
58
1.57
0.70
3.4
6.3
25.81
34.33
mg/l
—
9
53
44
359
1.27
0.70
1.7
1.7
224324704.38
409.55
pmol/l
0.49
37
316
10
61
1.67
0.69
1.6
1.6
—
—
—
0
0
5
27
1.87
0.69
1.0
1.2
190.60
266.64
pmol/l
—
5
22
5
27
1.87
0.69
2.0
1.4
0.67
0.56
e9/l
—
5
27
13
86
1.54
0.67
1.1
1.3
309.83
83.13
u/ml
—
6
33
46
392
1.21
0.52
4.0
2.3
1.46
1.52
%
0.26
40
341
6
40
1.51
0.52
1.7
2.0
—
—
—
0
0
5
31
1.62
0.43
1.4
1.0
—
1.10
—
0
14
8
59
1.37
0.41
1.4
1.8
—
—
—
0
0
37
321
1.18
0.36
3.5
3.1
2.45
2.44
mmol/l
0.14
32
289
14
111
1.28
0.30
1.2
1.5
—
—
—
0
0
7
56
1.26
0.29
2.1
1.8
—
—
—
0
0
11
85
1.31
0.28
1.3
3.9
4.22
4.59
pmol/l
—
6
78
8
67
1.20
0.26
1.5
1.3
—
—
—
0
0
5
40
1.25
0.22
1.4
1.2
—
—
—
0
0
5
40
1.25
0.22
1.4
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
6
50
1.20
0.20
3.0
1.3
—
—
—
0
0
11
132
0.83
0.18
1.1
1.1
1.36
1.42
g/l
0.46
11
132
9
81
1.12
0.15
1.8
1.2
—
—
—
0
0
18
198
0.90
0.11
3.2
3.0
—
—
—
0
0
17
154
1.11
0.10
2.5
1.7
0.20
0.35
mg/l
—
10
82
188
1855
1.05
0.10
25.0
18.9
335.97
335.75
g/l
0.12
188
1849
6
55
1.09
0.09
4.3
6.1
1.28
1.58
ratio
—
6
29
12
133
0.90
0.08
1.6
1.1
0.96
0.93
g/l
0.17
12
133
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.9
—
53.64
—
0
9
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
0.15
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
8.00
—
0
5
0
6
0.00
-0.00
0.0
4.2
—
5.56
—
0
6
5
50
1.00
-0.00
1.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
1.18
—
0
5
0
6
0.00
-0.00
0.0
4.2
—
9.97
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint N14_MALEGENINOTH and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| N14_MALEGENINOTH | 1.305 [1.07, 1.59] | 0.008 |
| Birth year | 0.987 [0.98, 1.0] | 0.007 |
During the follow-up period (1.1.1998 — 31.12.2019), 156 out of 1765 males with N14_MALEGENINOTH died.
Mortality risk
Mortality risk for people of age
years, who have N14_MALEGENINOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.236% |
| 5 | No data | 1.558% |
| 10 | No data | 3.758% |
| 15 | No data | 7.027% |
| 20 | No data | 11.796% |
Relationships between endpoints
↥Index endpoint: N14_MALEGENINOTH – Disorders of male genital organs in diseases classified elsewhere
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data